Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer
Taslim A. Al‐Hilal(University of Utah), David Lagares(Harvard University), Raghu Kalluri(The University of Texas MD Anderson Cancer Center), David T. Ting(Massachusetts General Hospital), Wolfgang H. Goldmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Clemens K. Probst(Harvard University), Andrew M. Tager(Harvard University), Charles R. Yates(University of Mississippi), Paula Grasberger(University of Massachusetts Chan Medical School), Tejaswini Reddi(Innovation Research Center), Alan C. Mullen(Broad Institute), José L. Alonso(Universidad de Valladolid), Tamanna Islam(University of Utah), K. Daneshvar(University of North Carolina at Charlotte), Adam J. Engler(University of California San Diego), Vera Auernheimer(Fraunhofer Institute for Biomedical Engineering), Daniel J. Tschumperlin(WinnMed), Delphine Sicard, Ludovic G. Vincent(Sanford Consortium for Regenerative Medicine), Eric S. White(Boehringer Ingelheim (United Kingdom)), Mark Anthony Leon Duque(Harvard University), Christina M. Woo(Harvard University), Cassandra Happe(Sanford Consortium for Regenerative Medicine), Matteo Ligorio(The University of Texas Southwestern Medical Center), Yan Zhou(Xuzhou Medical College), Zebin Xiao(University of Pennsylvania), Maria-Anna Chrysovergi(Harvard University), Edward Chaum(Vanderbilt University Medical Center), Fei Liu(Harvard University), Vladimir Vrbanac(Harvard University), Alba Santos(Harvard University), Ellen Puré(University of the Sciences)
Cited by 21
Related Papers
The basics of epithelial-mesenchymal transition
|Journal of Clinical Investigation|2009|10.1k
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Guidelines and definitions for research on epithelial–mesenchymal transition
|Nature Reviews Molecular Cell Biology|2020|2.3k